How would you treat CML and CLL that occurred together?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

How does the CLL17 trial presented at ASH 2025 change current practice guidelines?

What is your preferred 1L treatment for newly diagnosed Del(17p)/TP53 mutation, high-risk CLL?

Does the lack of long-term data influence your consideration of utilizing zanubrutinib and venetoclax 1L in High-Risk CLL?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Evidence Meets Expertise